Clinical Trial

Validation of the French Translation of the SOSI-M

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 20, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to validate the French version of the SOSI-M test on healthy children as well as on children with neurodevelopmental disorders (NDDs). Therefore, the investigators will conduct a video recording of the test administration on a group of healthy children and on a group of children with NDDs. The research question is: Is the French translation of the SOSI-M test equivalent, in terms of functionality and expected results, to the original version for a population of healthy children and children with mild to moderate neurodevelopmental disorders? The hypothesis is that the psychometric properties of the French version are similar to those of the original version. Secondly, the investigators will investigate: Does the difference in socio-cultural context between healthy Belgian and Senegalese children influence the SOSI-M score? The hypothesis is that healthy Belgian children obtain better scores compared to healthy Senegalese children. The scores of the two groups will be compared with each other and with those obtained in previous studies. Intra- and inter-rater reliability will also be assessed.
Trial Details
NCT Number NCT07353112
Lead Sponsor Haute Ecole Ilya Prigogine
Conditions Neurodevelopmental Disorders
Enrollment 60 participants
Start Date 2026-02
Primary Completion 2026-03 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2026-01-20